REQUEST A DEMO
Total
USD $0.00
Search more companies

Farmel Farmacos y Medicamentos CIA Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Farmel Farmacos y Medicamentos CIA Ltda Profile Updated: April 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Farmel Farmacos y Medicamentos CIA Ltda is an enterprise located in Ecuador, with the main office in Guayaquil. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on September 07, 1992. 6 (2023) employees currently work for Farmel Farmacos y Medicamentos CIA Ltda. In 2023, the company reported a net sales revenue drop of 12.99%. Over the same period, its total assets decreased by 11.69%. The enterprise’s net profit margin decreased by 2.99% in 2023.

Headquarters
Av.Carlos Julio Arosemena Tola Km. 2.7, Centro Comercial Alban Borja Bldg. , Floor 125
Guayaquil; Guayas;

Contact Details: Purchase the Farmel Farmacos y Medicamentos CIA Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Farmel Farmacos y Medicamentos CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Farmel Farmacos y Medicamentos CIA Ltda report to view the information.
Registered Capital:
Purchase the Farmel Farmacos y Medicamentos CIA Ltda report to view the information.
Incorporation Date:
September 07, 1992
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99.5%
Purchase this report to view the information.
0.5%
Company Performance
Financial values in the chart are available after Farmel Farmacos y Medicamentos CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-12.99%
Total operating revenue
-12.99%
Operating profit (EBIT)
-52.75%
Net Profit (Loss) for the Period
-56.39%
Total assets
-11.69%
Total equity
1.88%
Operating Profit Margin (ROS)
-4.35%
Net Profit Margin
-2.99%
Return on Equity (ROE)
-6.65%
Quick Ratio
0.71%
Cash Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?